January 15, 2018 by Chain Drug Review
EnvisionRx, Health Dialog, Kermit Crawford, RediClinic, Rite Aid, Walgreens Boots Alliance
2018, Issue 01-15-2018, Issues, News
CAMP HILL, Pa. — Rite Aid Corp. president and chief operating officer Kermit Crawford said he’s confident the company “will succeed in building the new Rite Aid” following its $4.375 billion asset sale to Walgreens Boots Alliance (WBA). Under the deal, announced in September, Rite Aid is selling 1,932 stores, three distribution centers and related
January 15, 2018 by Geoff Walden and Chain Drug Review
AmerisourceBergen, Brian Nightengale, community pharmacy, Elevate Provider Network, Good Neighbor Pharmacy, independent pharmacies, J.D. Power U.S. Pharmacy Study
2018, Featured Articles, Issue 01-15-2018, Issues, Leading Headlines, News, Retail News
VALLEY FORGE, Pa. — AmerisourceBergen Corp.’s backing, combined with the entrepreneurship of independent pharmacies, has made the company’s Good Neighbor Pharmacy network an exemplar of high-touch service, says senior vice president of community and specialty pharmacy and Good Neighbor Pharmacy president Brian Nightengale. AmerisourceBergen’s support tools and personnel enhance the inherent ability of independents to
January 15, 2018 by Scot Meyer and Chain Drug Review
CVS Health, CVS Health's 2018 earnings outlook, David Denton, Larry Merlo, Red Oak
2018, Issue 01-15-2018, Issues, News
WOONSOCKET, R.I. — CVS Health executives expressed confidence in the company’s growth strategy earlier this month, and also noted that the recently passed tax overhaul packaged should boost its cash flow by an estimated $1.2 billion. The remarks came in a conference call following an announcement of CVS Health’s 2018 earnings outlook. CVS Health said
January 15, 2018 by Brian Bossetta
Bridge of Hope Fund, drug abuse, Fruth Pharmacy, Joe Manchin, Lynne Fruth, Shelley Moore Capito
2018, Issue 01-15-2018, Issues, News
POINT PLEASANT, W.Va. — Drug abuse, including the abuse of prescription painkillers, has reached epidemic proportions in the U.S., and Fruth Pharmacy, based here, is on the front lines of the fight, says Lynne Fruth, the company’s chairman and president. Along with West Virginia, Fruth has stores in Ohio and Kentucky, all of which have
January 15, 2018 by Geoff Walden and Chain Drug Review
ACA open enrollment, Affordable Care Act, health insurance, Lindsey Graham, Mitch McConnell
2018, Issue 01-15-2018, Issues, News
WASHINGTON — Nearly 9 million people signed up for health insurance in the Affordable Care Act’s latest open enrollment period, despite the Trump administration having cut its duration in half. The 8.8 million enrollees were only slightly fewer than the total in the last ACA open enrollment period, which, besides being longer, was much more
January 15, 2018 by Jeffrey Woldt and Chain Drug Review
Beth Husted, Jeffrey Woldt, Lewis Drug, Mark Griffin, NACDS Regional Chain Conference, National Association of Chain Drug Stores, Ritzman Pharmacy
2018, Issue 01-15-2018, Issues, Leading Headlines, Opinion
With the National Association of Chain Drug Stores gearing up for its annual NACDS Regional Chain Conference, which will run from February 4 through February 6 in Fort Lauderdale, Fla., it is a good moment to appraise that segment of the community pharmacy industry. Greatly reduced in number by the consolidation wave that has repeatedly
January 15, 2018 by Chain Drug Review
B. Douglas Hoey, Center for Medicare & Medicaid Innovation, Centers for Medicare & Medicaid Services, CMS-4182-P Medicare Program, community pharmacies, DIR fees, Medicare Part D, National Community Pharmacists Association, NCPA, PBM business model, pharmacy benefit managers
2018, Issue 01-15-2018, Issues, Opinion
WASHINGTON — In recent testimony before the House of Representatives Energy and Commerce Subcommittee on Health, National Community Pharmacists Association (NCPA) chief executive officer B. Douglas Hoey said pharmacists can drive better health outcomes and reduce costs, but first pharmacy benefit managers’ problematic business practices must be addressed through legislative and regulatory channels. As an
January 4, 2018 by Jeffrey Woldt and Chain Drug Review
Chain Drug Review, H-E-B, Industry Leadership Award, Martin Otto, NACDS, NACDS chairman, National Association of Chain Drug Stores, Steve Anderson
2018, Featured Articles, Issue 01-01-2018, Issues, Leading Headlines, News, Retail News
SAN ANTONIO — Even the best-run, most effective organizations can benefit from occasionally reconsidering their work in a new light. The National Association of Chain Drug Stores is a case in point. Long viewed as the country’s preeminent retail trade group, NACDS has in recent months broadened and deepened its already formidable commitment to the
January 3, 2018 by Jeffrey Woldt and Chain Drug Review
Chain Drug Review, CVS Health, CVS Pharmacy, Kevin Hourican, Pharmacy Executive of the Year, ScriptPath
2018, Featured Articles, Issue 01-01-2018, Issues, Leading Headlines, News, Pharmacy, Retail News
WOONSOCKET, R.I. — Kevin Hourican is a relative newcomer to community pharmacy, but that hasn’t prevented him from helping CVS Health live up to its positioning as a pharmacy innovation company. Since being named executive vice president of retail pharmacy and supply chain 18 months ago, Hourican, who was trained in economics and supply chain
January 2, 2018 by Jeffrey Woldt and Chain Drug Review
Alex Gourlay, Chain Drug Review, Ornella Barra, Retailer of the Year, Retailer of the Year Award, Rite Aid, Walgreens, Walgreens Boots Alliance, WBA
2018, Featured Articles, Issue 01-01-2018, Issues, Leading Headlines, News, Retail News
DEERFIELD, Ill. — To the casual observer, the dominant story line at Walgreens might appear to be the phased acquisition of 1,932 drug stores and related assets from Rite Aid Corp., and plans for their subsequent assimilation. But, important as the deal is, it shouldn’t be allowed to obscure other compelling developments at Walgreens Boots
January 1, 2018 by Chain Drug Review
Affordable Care Act, B. Douglas Hoey, Bill Pascrell, federal tax overhaul, individual mandate, John Barrasso, John Cornyn, Jon Kingsdale, Lindsey Graham, Matthew Shay, Medicaid expansion, National Community Pharmacists Association, National Retail Federation, Obamacare, Sherrod Brown, tax reform legislation
2018, Issue 01-01-2018, Issues, Leading Headlines, News
WASHINGTON — The individual mandate is no more. The requirement under the Affordable Care Act that people pay a penalty if they do not obtain health insurance was eliminated in the federal tax overhaul passed by Congress. After the Senate approved the tax reform legislation 51-48, Trump tweeted, “Terrible Individual Mandate (ObamaCare) Repealed.” He signed
January 1, 2018 by Bill Schiffner
Gary Senecal, Jeff Leger, Loblaw, Mike Motz, Shoppers Drug Mart
2018, Issue 01-01-2018, Issues, News
TORONTO — Jeff Leger has been appointed president of Shoppers Drug Mart, succeeding Mike Motz, who has been promoted to chief operating officer of SDM parent Loblaw Cos. Leger had previously served as executive vice president of pharmacy and health care for both Loblaw and Shoppers Drug Mart stores. Prior to that, he was senior
January 1, 2018 by Geoff Walden and Chain Drug Review
chain drug store holiday sales, Heather Hughes, holiday retail sales, Jack Kleinhenz, National Retail Federation, Phil Rist, Prosper, Walgreens
2018, Issue 01-01-2018, Issues, News
NEW YORK — Chain drug store holiday sales bettered last year’s results, with total dollar volume rising more than 4% and same-store sales advancing 1.8%. In comparison to the 2016 holiday retail sales season, when anxiety over the new administration may have peaked, consumer confidence was up this year, propelled by income gains and the
January 1, 2018 by Bill Schiffner
Britt Vitalone, Chris Dimos, Cigna, Cigna Pharmacy, Health Mart, James Beer, John Hammergren, McKesson, McKesson U.S. Pharmaceutical, Steve Courtman
2018, Issue 01-01-2018, Issues, News
SAN FRANCISCO — McKesson Corp. announced two key personnel moves, including the promotion of Chris Dimos to president of retail solutions for McKesson U.S. Pharmaceutical and Specialty Health. Dimos will now oversee the Health Mart pharmacy network, taking over from Steve Courtman, who left the company to join health insurer Cigna as senior vice president